Literature DB >> 20570721

Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge.

Angela M Wynne1, Christopher J Henry, Yan Huang, Anthony Cleland, Jonathan P Godbout.   

Abstract

Fractalkine (CX(3)CL1) to fractalkine receptor (CX(3)CR1) interactions in the brain are involved in the modulation of microglial activation. Our recent findings indicate that there is microglial hyperactivity in the aged brain during an inflammatory challenge. The underlying cause of this amplified microglial response in the aged brain is unknown. Therefore, the purpose of this study was to determine the degree to which age-associated impairments of CX(3)CL1 and CX(3)CR1 in the brain contribute to exaggerated microglial activation after intraperitoneal (i.p.) injection of lipopolysaccharide (LPS). Here we show that CX(3)CL1 protein was reduced in the brain of aged (18-22 mo) BALB/c mice compared to adult (3-6 mo) controls. CX(3)CL1 protein, however, was unaltered by LPS injection. Next, CX(3)CR1 levels were determined in microglia (CD11b(+)/CD45(low)) isolated by Percoll density gradient separation at 4 and 24h after LPS injection. Flow cytometric and mRNA analyses of these microglia showed that LPS injection caused a marked decrease of CX(3)CR1 and a simultaneous increase of IL-1β at 4h after LPS injection. While surface expression of CX(3)CR1 was enhanced on microglia of adult mice by 24h, it was still significantly downregulated on a subset of microglia from aged mice. This protracted reduction of CX(3)CR1 corresponded with a delayed recovery from sickness behavior, prolonged IL-1β induction, and decreased TGFß expression in the aged brain. In the last set of studies BV2 microglia were used to determine effect of TGFß on CX(3)CR1. These results showed that TGFβ enhanced CX(3)CR1 expression and attenuated the LPS-induced increase in IL-1β expression.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570721      PMCID: PMC2939290          DOI: 10.1016/j.bbi.2010.05.011

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  47 in total

1.  Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation.

Authors:  V Zujovic; J Benavides; X Vigé; C Carter; V Taupin
Journal:  Glia       Date:  2000-02-15       Impact factor: 7.452

2.  ATP mediates rapid microglial response to local brain injury in vivo.

Authors:  Dimitrios Davalos; Jaime Grutzendler; Guang Yang; Jiyun V Kim; Yi Zuo; Steffen Jung; Dan R Littman; Michael L Dustin; Wen-Biao Gan
Journal:  Nat Neurosci       Date:  2005-05-15       Impact factor: 24.884

3.  Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide.

Authors:  Y Huang; C J Henry; R Dantzer; R W Johnson; J P Godbout
Journal:  Neurobiol Aging       Date:  2007-05-31       Impact factor: 4.673

4.  Differential effects and rates of normal aging in cerebellum and hippocampus.

Authors:  Diana S Woodruff-Pak; Michael R Foy; Garnik G Akopian; Ka Hung Lee; Jordan Zach; Kim Phuong Thi Nguyen; David M Comalli; John A Kennard; Alexis Agelan; Richard F Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

5.  Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation.

Authors:  Y Pan; C Lloyd; H Zhou; S Dolich; J Deeds; J A Gonzalo; J Vath; M Gosselin; J Ma; B Dussault; E Woolf; G Alperin; J Culpepper; J C Gutierrez-Ramos; D Gearing
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

6.  Functional expression of the fractalkine (CX3C) receptor and its regulation by lipopolysaccharide in rat microglia.

Authors:  E W Boddeke; I Meigel; S Frentzel; K Biber; L Q Renn; P Gebicke-Härter
Journal:  Eur J Pharmacol       Date:  1999-06-18       Impact factor: 4.432

7.  The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia.

Authors:  S A Boehme; F M Lio; D Maciejewski-Lenoir; K B Bacon; P J Conlon
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

8.  Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro.

Authors:  Anthony Lyons; Aileen M Lynch; Eric J Downer; Riona Hanley; Joan B O'Sullivan; Andrew Smith; Marina A Lynch
Journal:  J Neurochem       Date:  2009-07-15       Impact factor: 5.372

9.  Fractalkine protein localization and gene expression in mouse brain.

Authors:  G Tarozzo; S Bortolazzi; C Crochemore; S-C Chen; A S Lira; J S Abrams; M Beltramo
Journal:  J Neurosci Res       Date:  2003-07-01       Impact factor: 4.164

10.  New evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease.

Authors:  Sun Shan; Tang Hong-Min; Feng Yi; Gao Jun-Peng; Fan Yue; Tang Yan-Hong; Yang Yun-Ke; Li Wen-Wei; Wang Xiang-Yu; Ma Jun; Wang Guo-Hua; Huang Ya-Ling; Li Hua-Wei; Cai Ding-Fang
Journal:  Neurobiol Aging       Date:  2009-04-14       Impact factor: 4.673

View more
  112 in total

Review 1.  Cognitive and behavioral consequences of impaired immunoregulation in aging.

Authors:  Angela W Corona; Ashley M Fenn; Jonathan P Godbout
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-20       Impact factor: 4.147

Review 2.  Aging-related changes in neuroimmune-endocrine function: implications for hippocampal-dependent cognition.

Authors:  Ruth M Barrientos; Matthew G Frank; Linda R Watkins; Steven F Maier
Journal:  Horm Behav       Date:  2012-02-18       Impact factor: 3.587

3.  Little exercise, big effects: reversing aging and infection-induced memory deficits, and underlying processes.

Authors:  Ruth M Barrientos; Matthew G Frank; Nicole Y Crysdale; Timothy R Chapman; Jared T Ahrendsen; Heidi E W Day; Serge Campeau; Linda R Watkins; Susan L Patterson; Steven F Maier
Journal:  J Neurosci       Date:  2011-08-10       Impact factor: 6.167

4.  Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge.

Authors:  Diana M Norden; Paige J Trojanowski; Emmanuel Villanueva; Elisa Navarro; Jonathan P Godbout
Journal:  Glia       Date:  2015-10-15       Impact factor: 7.452

5.  Pancreatic stellate cells and CX3CR1: occurrence in normal pancreas and acute and chronic pancreatitis and effect of their activation by a CX3CR1 agonist.

Authors:  Masahiko Uchida; Tetsuhide Ito; Taichi Nakamura; Masayuki Hijioka; Hisato Igarashi; Takamasa Oono; Masaki Kato; Kazuhiko Nakamura; Koichi Suzuki; Ryoichi Takayanagi; Robert T Jensen
Journal:  Pancreas       Date:  2014-07       Impact factor: 3.327

6.  Age-dependent changes on TGFβ1 Smad3 pathway modify the pattern of microglial cell activation.

Authors:  Juan E Tichauer; Betsi Flores; Bernardita Soler; Laura Eugenín-von Bernhardi; Gigliola Ramírez; Rommy von Bernhardi
Journal:  Brain Behav Immun       Date:  2013-12-29       Impact factor: 7.217

Review 7.  Microglial phenotype and adaptation.

Authors:  B J L Eggen; D Raj; U-K Hanisch; H W G M Boddeke
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

Review 8.  Review: microglia of the aged brain: primed to be activated and resistant to regulation.

Authors:  D M Norden; J P Godbout
Journal:  Neuropathol Appl Neurobiol       Date:  2013-02       Impact factor: 8.090

9.  Voluntary wheel running does not affect lipopolysaccharide-induced depressive-like behavior in young adult and aged mice.

Authors:  Stephen A Martin; Robert Dantzer; Keith W Kelley; Jeffrey A Woods
Journal:  Neuroimmunomodulation       Date:  2013-11-20       Impact factor: 2.492

10.  Aging leads to prolonged duration of inflammation-induced depression-like behavior caused by Bacillus Calmette-Guérin.

Authors:  Keith W Kelley; Jason C O'Connor; Marcus A Lawson; Robert Dantzer; Sandra L Rodriguez-Zas; Robert H McCusker
Journal:  Brain Behav Immun       Date:  2013-02-26       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.